This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis of liver cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Hepatoma is invariably and rapidly fatal - without treatment, the average survival time from diagnosis is less than six months. The only hope of a cure is resection or liver transplantation. With surgical intervention, the 5 year survival is approximately 20%.

Metastases are unusual, but when they occur they are small and travel to lung and bone.

Liver cancer mortality is strongly related to age, with the highest mortality rates being in older people

  • in the UK in 2014-2016, on average each year half (50%) of deaths were in people aged 75 and over
  • largely reflects higher incidence and lower survival for liver cancer in older people
  • age-specific mortality rates rise steadily from around age 45-49 and more steeply from around age 60-64
  • highest rates are in the 85 to 89 age group for males and females
  • mortality rates are significantly higher in males than females in a number of (mainly older) age groups. The gap is widest at age 60 to 64, when the age-specific mortality rate is 2.3 times higher in males than females.

 

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.